Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Roberts

Showing results (141-150 of 171) with videos related to

Pageof 18
Sort By:
BJU International|January 28, 2026
Focal therapy using a novel cooled laser device for prostate cancer: early trial resultsJonathan Kam, Bishoy Hanna, Stuart Jackson, et al.
The Prostate|January 20, 2015
Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancerMatthew J Roberts, Clement W K Chow, Horst Joachim Schirra, et al.
ACS Nano|July 21, 2018
Design and Clinical Verification of Surface-Enhanced Raman Spectroscopy Diagnostic Technology for Individual Cancer Risk PredictionKevin M Koo, Jing Wang, Renée S Richards, et al.
Urologic Oncology|December 13, 2021
The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparisonArsalan Tariq, Michael Kwok, Adam Pearce, et al.
The Science of the Total Environment|December 9, 2023
Reclassifying historical disasters: From single to multi-hazardsRyan Lee, Christopher J White, Mohammed Sarfaraz Gani Adnan, et al.
Urologic Oncology|April 25, 2022
Characterization of tumor thrombus in renal cell carcinoma with prostate specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT)Arsalan Tariq, Stephen McGeorge, Adam Pearce, et al.
European Urology Oncology|April 13, 2025
An Online Treatment Decision Aid for Men with Low-risk Prostate Cancer Eligible for Active Surveillance and Their Partners Increases the Uptake of Active Surveillance: The Navigate Randomised Controlled TrialPenelope Schofield, Stephen Quinn, Natalie Richards, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 27, 2026
Rapid Decentralized Prostate Cancer Risk Stratification by Portable Liquid Biopsy Analysis within a Clinical Biosensor Validation FrameworkKevin M Koo, Grant Phillips, Sriganesh Srihari, et al.
European Urology Open Science|July 13, 2023
A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate BiopsyBrian D Kelly, Gideon Ptasznik, Matthew J Roberts, et al.
BJU International|November 13, 2022
Synchronous vs independent reading of prostate-specific membrane antigen positron emission tomography (PSMA-PET) and magnetic resonance imaging (MRI) to improve diagnosis of prostate cancerPaul Doan, William Counter, Nathan Papa, et al.
Pageof 18

Showing results (141-150 of 171) with videos related to

Sort By:
Pageof 18
BJU International|January 28, 2026
Focal therapy using a novel cooled laser device for prostate cancer: early trial resultsJonathan Kam, Bishoy Hanna, Stuart Jackson, et al.
The Prostate|January 20, 2015
Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancerMatthew J Roberts, Clement W K Chow, Horst Joachim Schirra, et al.
ACS Nano|July 21, 2018
Design and Clinical Verification of Surface-Enhanced Raman Spectroscopy Diagnostic Technology for Individual Cancer Risk PredictionKevin M Koo, Jing Wang, Renée S Richards, et al.
Urologic Oncology|December 13, 2021
The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparisonArsalan Tariq, Michael Kwok, Adam Pearce, et al.
The Science of the Total Environment|December 9, 2023
Reclassifying historical disasters: From single to multi-hazardsRyan Lee, Christopher J White, Mohammed Sarfaraz Gani Adnan, et al.
Urologic Oncology|April 25, 2022
Characterization of tumor thrombus in renal cell carcinoma with prostate specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT)Arsalan Tariq, Stephen McGeorge, Adam Pearce, et al.
European Urology Oncology|April 13, 2025
An Online Treatment Decision Aid for Men with Low-risk Prostate Cancer Eligible for Active Surveillance and Their Partners Increases the Uptake of Active Surveillance: The Navigate Randomised Controlled TrialPenelope Schofield, Stephen Quinn, Natalie Richards, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 27, 2026
Rapid Decentralized Prostate Cancer Risk Stratification by Portable Liquid Biopsy Analysis within a Clinical Biosensor Validation FrameworkKevin M Koo, Grant Phillips, Sriganesh Srihari, et al.
European Urology Open Science|July 13, 2023
A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate BiopsyBrian D Kelly, Gideon Ptasznik, Matthew J Roberts, et al.
BJU International|November 13, 2022
Synchronous vs independent reading of prostate-specific membrane antigen positron emission tomography (PSMA-PET) and magnetic resonance imaging (MRI) to improve diagnosis of prostate cancerPaul Doan, William Counter, Nathan Papa, et al.
Pageof 18